000 | 01291 a2200337 4500 | ||
---|---|---|---|
005 | 20250512151859.0 | ||
264 | 0 | _c19680807 | |
008 | 196808s 0 0 eng d | ||
022 | _a0022-2623 | ||
024 | 7 |
_a10.1021/jm00309a018 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBaker, B R | |
245 | 0 | 0 |
_aIrreversible enzyme inhibitors. CXIX. Active-site-directed irreversible inhibitors of dihydrofolic reductase with tissue specificity derived from 2,4,6-triaminopyrimidine with a terminal sulfonyl fluoride at the 5 position. _h[electronic resource] |
260 |
_bJournal of medicinal chemistry _cMay 1968 |
||
300 |
_a489-94 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBinding Sites |
650 | 0 | 4 |
_aCarcinoma 256, Walker _xenzymology |
650 | 0 | 4 |
_aFluorides _xchemical synthesis |
650 | 0 | 4 | _aFolic Acid Antagonists |
650 | 0 | 4 |
_aLeukemia L1210 _xenzymology |
650 | 0 | 4 |
_aLiver _xenzymology |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aPyrimidines _xchemical synthesis |
650 | 0 | 4 | _aRats |
650 | 0 | 4 |
_aSulfonic Acids _xchemical synthesis |
700 | 1 | _aMeyer, R B | |
773 | 0 |
_tJournal of medicinal chemistry _gvol. 11 _gno. 3 _gp. 489-94 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm00309a018 _zAvailable from publisher's website |
999 |
_c5243235 _d5243235 |